Galapagos NV
GLPG
#4545
Rank
NZ$3.71 B
Marketcap
NZ$55.59
Share price
2.21%
Change (1 day)
18.54%
Change (1 year)

Galapagos NV (GLPG) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$7.08 Billion

According to Galapagos NV's latest financial reports the company's total assets are NZ$7.08 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Galapagos NV - Total assets on balance sheet (from 2008 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$7.63 B0.19%
2023-12-31NZ$7.61 B-4.77%
2022-12-31NZ$7.99 B-7.1%
2021-12-31NZ$8.61 B-11.66%
2020-12-31NZ$9.74 B-3.44%
2019-12-31NZ$10.09 B311.16%
2018-12-31NZ$2.45 B12.97%
2017-12-31NZ$2.17 B32.1%
2016-12-31NZ$1.64 B132.7%
2015-12-31NZ$0.70 B68.39%
2014-12-31NZ$0.41 B-13.07%
2013-12-31NZ$0.48 B27.63%
2012-12-31NZ$0.37 B41.2%
2011-12-31NZ$0.26 B-19.86%
2010-12-31NZ$0.33 B17.97%
2009-12-31NZ$0.28 B-0.97%
2008-12-31NZ$0.28 B0.97%
2007-12-31NZ$0.28 B-9.71%
2006-12-31NZ$0.31 B122.12%
2005-12-31NZ$0.14 B376.26%
2004-12-31NZ$29.68 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
AstraZeneca
AZN
NZ$196.80 B 2,677.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$331.54 B 4,578.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$261.92 B 3,595.81%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
NZ$230.23 B 3,148.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
NZ$0.27 B-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$144.74 B 1,942.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$68.53 B 867.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$141.79 B 1,900.72%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$222.75 B 3,043.15%๐Ÿ‡บ๐Ÿ‡ธ USA